Thomas McCauley
Chief Tech/Sci/R&D Officer bij OMEGA THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Thomas McCauley is currently the Chief Scientific Officer at Omega Therapeutics, Inc. Prior to this, he held the same position at Zikani Therapeutics, Inc. from 2018 to 2019 and at Translate Bio, Inc. from 2016 to 2018.
He was also the Vice President at Shire Pharmaceuticals, Inc. from 2010 to 2016.
McCauley received his undergraduate degree from Cornell University and his doctorate from The University of Alabama at Birmingham.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OMEGA THERAPEUTICS, INC.
-.--% | 07-02-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Thomas McCauley
| Bedrijven | Functie | Begin |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-07-2019 |
Eerdere bekende functies van Thomas McCauley
| Bedrijven | Functie | Einde |
|---|---|---|
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 01-07-2019 |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 01-04-2018 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01-08-2016 |
Opleiding van Thomas McCauley
| Cornell University | Undergraduate Degree |
| The University of Alabama at Birmingham | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Retail Trade |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
